{"nct_id":"NCT03797326","title":"Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2019-02-12","start_date_type":"ACTUAL","primary_completion_date":"2024-10-28","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}